1. Home
  2. ARQT vs USAC Comparison

ARQT vs USAC Comparison

Compare ARQT & USAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$28.05

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

USAC

USA Compression Partners LP

HOLD

Current Price

$26.88

Market Cap

4.1B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
USAC
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
ARQT
USAC
Price
$28.05
$26.88
Analyst Decision
Strong Buy
Hold
Analyst Count
6
3
Target Price
$34.00
$26.67
AVG Volume (30 Days)
1.7M
273.7K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
7.72%
EPS Growth
88.79
N/A
EPS
N/A
N/A
Revenue
$376,072,000.00
$698,365,000.00
Revenue This Year
$34.85
$33.35
Revenue Next Year
$29.39
$6.09
P/E Ratio
N/A
$31.25
Revenue Growth
91.34
19.51
52 Week Low
$13.70
$21.85
52 Week High
$31.77
$30.55

Technical Indicators

Market Signals
Indicator
ARQT
USAC
Relative Strength Index (RSI) 61.54 50.61
Support Level $27.63 $25.98
Resistance Level $29.91 $28.79
Average True Range (ATR) 1.20 0.80
MACD -0.06 0.11
Stochastic Oscillator 62.20 65.85

Price Performance

Historical Comparison
ARQT
USAC

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About USAC USA Compression Partners LP

USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.

Share on Social Networks: